Cognitive & Nootropic

Cerebrolysin

FPE 1070

Porcine-brain peptide mixture (EVER Pharma), not a single sequence. Registered in many countries. Not an FDA Alzheimer or stroke drug. Ampules are not 5 mg cakes.

Not FDA-approved - research chemical
Reviewed by CalcMyPeptide Editorial Team
Last updated: August 2026Evidence: Moderate2 peer-reviewed citations
Typical research dose
5-30 mL/day (IV/IM)
Frequency
1× daily for 10-20 days
Half-life
Peptide mixture; rapid CNS penetration
Common vials
N/A (oral)
CAS
12656-17-6
Molecular weight
Mixture (<10 kDa peptides)

Use-case scores

0–10 against the evidence we have, not a gym ranking. Hidden domains do not apply here.

  • Cognition6/10

    Human stroke/dementia trials exist in countries where it is registered. Ceiling 6.5 for that class; haircut because it is a mixture, not a US NDA, and this page will not treat Alzheimer disease.

Compound card

Sequence
Porcine brain hydrolysate (not a single sequence)
Class
Peptide mixture (EVER Pharma); not FDA-approved
Formula
Mixture of low MW neuropeptides + amino acids
Status
Not FDA-approved · research use

How it works

Cerebrolysin is a porcine brain-derived peptide preparation containing low-molecular-weight neuropeptides and free amino acids, produced by controlled enzymatic proteolysis of lipid-free porcine brain proteins. It contains neurotrophic factors analogous to BDNF, CNTF, and GDNF.

Cerebrolysin promotes neurogenesis, synaptogenesis, neuronal survival, and recovery from ischemic damage via multimodal neurotrophic factor signaling. It is approved in 40+ countries for stroke, TBI, Alzheimer's disease, and vascular dementia.

Source: PMID: 21281685

Background & History

Cerebrolysin is a porcine-brain peptide mixture (EVER Pharma), not a single sequence. Registered in many countries. Not an FDA Alzheimer or stroke drug. Ampules are not 5 mg cakes.

Research Use Cases

  • ✓Mixture identity vs Semax vs Cortexin
  • ✓Why country registrations are not a US NDA
  • ✓Not a stroke, TBI, dementia, or Long-COVID protocol

Dosing

PhaseDoseFrequencyNotes
Cognitive Enhancement / Nootropic5 - 10 mL10-20 days, daily IV or IMLower nootropic doses. IV preferred for >5 mL. Run as a course with rest periods.
TBI / Stroke Recovery10 - 30 mLDaily IV for 10-30 days (clinical protocol)Approved protocol for neurological injury. Administered in clinic via slow IV infusion.

Administration

Route / form
Intravenous infusion or intramuscular injection ONLY
Timing
Morning. NOT subcutaneous.
Empty stomach?
No - Food timing is not critical.

Timeline

Day 3-7
Improved alertness, concentration, and mental energy.
Week 2-4
Neuroprotective and neurotrophic effects. Improved memory consolidation.
Month 1-3 (TBI/stroke)
Motor and cognitive recovery. Neurogenesis markers improve.

Who it is for

Mixture identity / ex-US registrations

Moderate

Registered in many countries. Not a US NDA. Ampules are not 5 mg cakes.

Stroke / TBI / dementia treatment page

Low

Trials exist where it is registered. This site will not treat those from a peptide calculator.

Safety & Considerations

Approved in 40+ countries. Administered IV or IM ONLY - NOT subcutaneous. Generally well-tolerated. May cause headache, dizziness, or injection site reactions. Contraindicated in severe renal impairment and status epilepticus.

Regulatory & Legal Status

FDA Status (US)
Research Only

Approved in 40+ countries for neurological indications; not FDA-approved in the US

WADA Status (2026)
Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change - verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Limits of current evidence

  • Mixture identity. There is no one amino-acid sequence to verify on a COA the way you verify BPC-157.
  • This site will not treat stroke, TBI, or dementia from a peptide page.
  • Do not force ampule math into a 5 mg BAC calculator.

Verdict

Cerebrolysin is a porcine-brain peptide mixture, not Semax in a bottle. Registered in many countries. Not an FDA Alzheimer drug. Ampules are not reconstitution cakes.

Interactions & Contraindications

Do not mix with 5-HT solutions per product literature. This page will not treat stroke from a peptide calculator.

Synergies & Common Stacks

+ Semax →

Mixture plus ACTH-fragment analog. Complementary neurotrophin marketing is not a combo RCT.

Frequently Asked Questions

Is Cerebrolysin available in the US?▼
Cerebrolysin is not FDA-approved in the US but is approved in 40+ countries. Some US physicians prescribe it off-label. It is most widely used in Europe, Russia, and Asia for neurological conditions.
How is Cerebrolysin administered?▼
5-30 mL daily via IV infusion or intramuscular injection for 10-20 day courses. IV is preferred for higher doses (>10 mL). Cerebrolysin is NOT a subcutaneous injection peptide.

References

  1. Chen CC et al. “"Cerebrolysin in stroke: a systematic review".” Brain Sciences (2020). PMID: 33286506
  2. Ruther E, et al. “Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized trial.” J Neural Transm (2000). PMID: 10960558

Looking for a trusted source? See our recommended suppliers

Independently tested · COA-verified · Save 10% with our exclusive code

See suppliers →
← Back to Peptide Library